Drugs for LMA insertio
Phase 3
- Conditions
- Health Condition 1: K353- Acute appendicitis with localizedperitonitisHealth Condition 2: D369- Benign neoplasm, unspecified siteHealth Condition 3: N29- Other disorders of kidney and ureter in diseases classified elsewhereHealth Condition 4: L768- Other intraoperative and postprocedural complications of skin and subcutaneous tissueHealth Condition 5: M248- Other specific joint derangements,not elsewhere classifiedHealth Condition 6: K928- Other specified diseases of the digestive system
- Registration Number
- CTRI/2022/02/040264
- Lead Sponsor
- Meenakshi Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA 1&2,
Posted for Short Elective Surgical Procedures
Exclusion Criteria
Patient with history of Upper respiratory infections,
K/C/O Bronchial asthma, Burns,Obesity,
H/O drug allergy,
Patient with anticipated difficult airway,
Patient with increased risk of regurgitation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient movements was more with propofol alone compared to propofol with lowdose scoline.Timepoint: 0 min <br/ ><br>3 min <br/ ><br>5 min <br/ ><br>10 min <br/ ><br>15 min <br/ ><br>30 min <br/ ><br>45 min <br/ ><br>60 min <br/ ><br>75 min <br/ ><br>90 min <br/ ><br>120 min
- Secondary Outcome Measures
Name Time Method Heart rate, Systolic BP, Diastolic BP, SpO2, and RR. <br/ ><br>No significant changes in hemodynamic parameters were there for both groupsTimepoint: 0 min <br/ ><br>3 min <br/ ><br>5 min <br/ ><br>10 min <br/ ><br>15 min <br/ ><br>30 min <br/ ><br>45 min <br/ ><br>60 min <br/ ><br>75 min <br/ ><br>90 min <br/ ><br>120 min